Kay M. Ristow

ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes

Edgardo R. Parrilla Castellar, Elaine S. Jaffe, Jonathan Said et al. · Blood · 2014 · 466 citations · Full text

Medicine, Oncology, Pathology +16

Bleomycin Pulmonary Toxicity Has a Negative Impact on the Outcome of Patients With Hodgkin's Lymphoma

William G. Martin, Kay M. Ristow, Thomas M. Habermann et al. · Journal of Clinical Oncology · 2005 · 303 citations · Full text

Medicine, Hematology, Oncology +17

The clinical spectrum of Castleman's disease

Angela Dispenzieri, Jamés O. Armitage, Matt J. Loe et al. · American Journal of Hematology · 2012 · 239 citations · Full text

Medicine, Hematology, Pathology +11

Expression of BLyS and its receptors in B-cell non-Hodgkin lymphoma: correlation with disease activity and patient outcome

Anne J. Novak, Deanna M. Grote, Mary Stenson et al. · Blood · 2004 · 234 citations · Full text

Medicine, Hematology, Oncology +13

Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in classical Hodgkin's lymphoma

Luis F. Porrata, Kay M. Ristow, Joseph P. Colgan et al. · Haematologica · 2011 · 209 citations · Full text

Medicine, Hematology, Oncology +16